The Relationship between Serum Amyloid A Level and Cognitive Dysfunction in Patients with Vascular Dementia: Preliminary Findings

Table 1

Clinical and biochemical characteristics of all subjects.

Item	VAD group ()	Normal group ()
Age (years)			>0.05
Sex (M/F)	76/70	38/32	>0.05
Smoke (, %)	34 (23.28%)	17 (24.28%)	>0.05
Hypertension (,%)	51 (19.02%)	15 (18.75%)	>0.05
DM (,%)	25 (17.12%)	11 (15.71%)	>0.05
Drinking habit (,%)	49 (33.75%)	22 (31.43%)	>0.05
BUA (μmol/l)			>0.05
TC (mmol/l)			>0.05
TG (mmol/l)			>0.05
HDL-C (mmol/l)			>0.05
LDL-C (mmol/l)			>0.05
AST/ALT			>0.05
BMI (kg/m^2)			>0.05
Scr (μmol/l)			>0.05
SBP (mmHg)			>0.05
DBP (mmHg)			>0.05
HLP (, %)	30 (20.54%)	14 (20.00%)	>0.05
Education (years)			<0.05
MMSE (points)			<0.05
SAA (mg/l)			<0.05

NC: normal controls; VAD: vascular dementia; SAA: serum amyloid A; HBP: high blood pressure; SBP: systolic blood pressure; DBP: diastolic blood pressure; HLP: hyperlipidemia; TC: total cholesterol; TG: triglycerides; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; DM: diabetes mellitus; MMSE: Mini-Mental State Examination; Scr: serum creatinine; BUA: blood urea nitrogen.